Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sylk vaginal moisturiser
21230000110
|
Sylk vaginal moisturiser | Vaginal Moisturisers | Appliances | 10,681 |
|
Dexcom One Transmitter
21480000106
|
Dexcom One Transmitter | Detection Sensor Interstitial Fluid/Gluc | Appliances | 10,676 |
|
Adapt No-Sting medical adhesive remover aerosol
23150101504
|
Adapt No-Sting medical adhesive remover aerosol | Adhesive Removers (Sprays/Liquids/Wipes) | Stoma Appliances | 10,674 |
|
Cacit D3 effervescent granules sachets
0906040G0BPAABX
|
Cacit D3 | Colecalciferol | Nutrition and Blood | 10,673 |
|
Imipramine 10mg tablets
0403010N0AAADAD
|
Imipramine hydrochloride | Imipramine hydrochloride | Central Nervous System | 10,666 |
|
Buprenorphine 400microgram sublingual tablets sugar free
0407020B0AAADAD
|
Buprenorphine (Opioid Analgesic) | Buprenorphine | Central Nervous System | 10,615 |
|
Sevodyne 15micrograms/hour transdermal patches
0407020B0BMADAK
|
Sevodyne | Buprenorphine | Central Nervous System | 10,605 |
|
BD Micro-Fine + hypod insulin needles for pre-filled / reusable pen injectors screw on 8mm/31gauge
21010900601
|
BD Micro-Fine + hypod insulin needles for pre-filled / reusable pen injectors screw on 8mm/31gauge | Other Appliances | Appliances | 10,597 |
|
Humalog 100units/ml solution for injection 10ml vials
0601011L0BBABAB
|
Insulin Humalog | Insulin Lispro | Endocrine System | 10,596 |
|
Aymes Shake powder 57g sachets strawberry
0913011C0BBAFAH
|
Aymes powder 1.6 kcal/ml milkshake | Powder 1.6 kcal/ml milkshake (0913011) | Nutrition and Blood | 10,577 |
|
Duloxetine 120mg gastro-resistant capsules
0403040Y0AAADAD
|
Duloxetine hydrochloride (Antidepressant) | Duloxetine hydrochloride | Central Nervous System | 10,574 |
|
SpeediCath Compact catheter female 8Ch-14Ch
21020001190
|
SpeediCath Compact catheter female 8Ch-14Ch | Catheters | Appliances | 10,564 |
|
SMA Alfamino powder
0913107A0BBAAAA
|
SMA powder amino acid formula | Powder amino acid formula (0913107) | Nutrition and Blood | 10,558 |
|
Indometacin 25mg capsules
1001010K0AAAAAA
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | 10,548 |
|
Mezolar Matrix 25micrograms/hour transdermal patches
0407020A0BFABAE
|
Mezolar Matrix | Fentanyl | Central Nervous System | 10,547 |
|
Tizanidine 4mg tablets
1002020T0AAAAAA
|
Tizanidine hydrochloride | Tizanidine hydrochloride | Musculoskeletal and Joint Diseases | 10,531 |
|
Softpore dressing 10cm x 10cm
20030100371
|
Softpore dressing 10cm x 10cm | Wound Management & Other Dressings | Dressings | 10,528 |
|
Phosphates enema (Formula B) 128ml standard tube
0106040N0AAABAB
|
Phosphate (Rectal) | Phosphates (Rectal) | Gastro-Intestinal System | 10,527 |
|
Altraplen Compact Daily liquid (4 flavours)
0913011X0BCABAD
|
Altraplen ready to serve 2.4 kcal/ml milkshake higher volume | Ready to serve 2.4 kcal/ml milkshake higher volume (0913011) | Nutrition and Blood | 10,523 |
|
Rivastigmine 4.6mg/24hours transdermal patches
0411000E0AAAFAF
|
Rivastigmine | Rivastigmine | Central Nervous System | 10,505 |
|
Cefalexin 250mg/5ml oral suspension
0501021L0AAADAD
|
Cefalexin | Cefalexin | Infections | 10,499 |
|
Prosys all silicone catheter male 12Ch-18Ch
21020001033
|
Prosys all silicone catheter male 12Ch-18Ch | Catheters | Appliances | 10,482 |
|
Eliquis 5mg tablets
0208020Z0BBABAB
|
Eliquis | Apixaban | Cardiovascular System | 10,479 |
|
Havrix Junior Monodose vacc inj 0.5ml pre-filled syringes
140400030BBADAD
|
Havrix | Hepatitis A | Immunological Products and Vaccines | 10,453 |
|
Cinchocaine 5mg / Hydrocortisone 5mg suppositories
0107020J0AAAFAF
|
Hydrocortisone compound preparations | Hydrocortisone | Gastro-Intestinal System | 10,451 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.